Latest Operational Efficiency News

Kogan.com reports robust first-half FY25 results with double-digit growth in sales and profits, driven by strategic marketing and a major digital upgrade at Mighty Ape despite initial setbacks.

Top Shelf International Holdings Ltd has agreed to sell its Campbellfield production assets to Idyll Wine Co for $8 million, aiming to streamline operations and reduce debt. The deal paves the way for a new co-packing partnership post-sale.

SomnoMed Limited reported a solid cash flow performance for Q4 2024, with operating activities generating a net inflow of $1.525 million and ending the quarter with $18.5 million in cash reserves.

SomnoMed reports a robust 19.8% revenue increase in Q2 FY25 and updates its full-year guidance, reflecting strong demand and operational improvements amid ongoing production enhancements.

BSA Limited reported a robust Q2 FY2025 with revenue up 10.7% and EBITDA surging 31.5%, underpinned by a key contract extension with nbn. The company has upgraded its full-year EBITDA guidance, signaling confidence in sustained profitability.

Aquirian’s subsidiary Western Energetics has secured a $20 million, three-year supply agreement with Mt Ida Goldmine, delivering innovative energetics and technology solutions that promise cost savings and environmental benefits.

Fertoz Limited reports solid Q4 2024 sales despite Canadian permit delays and plans a strategic rebrand to Canadian Phosphate Limited to align with its growth ambitions.

Synlait Milk Limited projects a return to profitability in HY25 with EBITDA guidance between $58 million and $63 million, underpinned by strategic growth and cost control. The company also enhances its financial incentives to secure South Island milk supply for the next three seasons.

Bioxyne Limited has raised its FY2025 revenue forecast to $25 million, driven by a remarkable 267% increase in first-half revenue and strong momentum from its subsidiary Breathe Life Sciences.

InhaleRx has locked in a $38.5 million funding deal with Clendon Biotech Capital, enabling expanded Phase 2 trials for its inhaled breakthrough cancer pain and panic disorder treatments. The company also filed a key international patent, positioning itself for a faster path to FDA approval.

Vonex Limited reports solid operational improvements and customer satisfaction in Q2 FY25, while endorsing Maxo Telecommunications’ takeover offer and planning a $13 million capital raise to manage debt.

Investigator Resources Limited has postponed the Definitive Feasibility Study (DFS) for its Paris Silver Project to mid-2025, citing rising costs and the need for further optimisation. Meanwhile, exploration drilling continues and asset sales bolster the company’s cash position to $2.7 million.